Cite
HARVARD Citation
Mathew, A. et al. (2018). Can estrogen receptor status predict for shorter duration of adjuvant trastuzumab in early-stage breast cancer?. Annals of oncology. pp. 2391-2392. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mathew, A. et al. (2018). Can estrogen receptor status predict for shorter duration of adjuvant trastuzumab in early-stage breast cancer?. Annals of oncology. pp. 2391-2392. [Online].